Herpes Labialis (Oral Herpes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Oral herpes is an infection of the lips, mouth, or gums due to the herpes simplex virus. Its symptoms include sore throat, fever, swollen glands, and painful swallowing.
The Herpes Labialis pipeline market research report provides comprehensive information on the therapeutics under development for Herpes Labialis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Herpes Labialis and features dormant and discontinued projects.
Herpes Labialis Pipeline Products Market Segmentation by Targets
The key targets in the Herpes Labialis pipeline products market are Cannabinoid Receptor 2, Prostaglandin G/H Synthase 2, DNA, DNA Helicase, DNA Primase, Fibroblast Growth Factor, Lipopolysaccharide, and Matrix Metalloproteinase 9.
Herpes Labialis Pipeline Products Market Analysis by Targets
For more target insights into the Herpes Labialis pipeline products market, download a free report sample
Herpes Labialis Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Herpes Labialis pipeline products market are Cannabinoid Receptor 2 Agonist, Prostaglandin G/H Synthase 2 Inhibitor, DNA Helicase Inhibitor, DNA Primase Inhibitor, DNA Synthesis Inhibitor, Fibroblast Growth Factor Inhibitor, Lipopolysaccharide Inhibitor, and Matrix Metalloproteinase 9 Inhibitor.
Herpes Labialis Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights into the Herpes Labialis pipeline products market, download a free report sample
Herpes Labialis Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the Herpes Labialis pipeline products market are topical, oral, intravenous, intravitreal, nasal, and vaginal.
Herpes Labialis Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights into the Herpes Labialis pipeline products market, download a free report sample
Herpes Labialis Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Herpes Labialis pipeline products market are small molecule, synthetic peptide, live attenuated vaccine, and monoclonal antibody.
Herpes Labialis Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Herpes Labialis pipeline products market, download a free report sample
Herpes Labialis Pipeline Products Market – Competitive Landscape
The leading companies in the Herpes Labialis pipeline products market are Jupiter Wellness Inc, NanoViricides Inc, Shulov Innovative Science Ltd, AiCuris Anti-infective Cures AG, Astellas Pharma Inc, Brandenburg Antiinfektiva GmbH, Dobecure SL, Heidelberg Immunotherapeutics Gmbh, Rational Vaccines Inc, and Vironova Medical AB.
Herpes Labialis Pipeline Products Market Analysis by Companies
To know more about the leading players in the Herpes Labialis pipeline products market, download a free report sample
Herpes Labialis Pipeline Products Market Report Overview
Key Targets | Cannabinoid Receptor 2, Prostaglandin G/H Synthase 2, DNA, DNA Helicase, DNA Primase, Fibroblast Growth Factor, Lipopolysaccharide, and Matrix Metalloproteinase 9 |
Key Mechanisms of Action | Cannabinoid Receptor 2 Agonist, Prostaglandin G/H Synthase 2 Inhibitor, DNA Helicase Inhibitor, DNA Primase Inhibitor, DNA Synthesis Inhibitor, Fibroblast Growth Factor Inhibitor, Lipopolysaccharide Inhibitor, and Matrix Metalloproteinase 9 Inhibitor |
Key Routes of Administration | Topical, Oral, Intravenous, Intravitreal, Nasal, and Vaginal |
Key Molecule Type | Small Molecule, Synthetic Peptide, Live Attenuated Vaccine, and Monoclonal Antibody |
Leading Companies | Jupiter Wellness Inc, NanoViricides Inc, Shulov Innovative Science Ltd, AiCuris Anti-infective Cures AG, Astellas Pharma Inc, Brandenburg Antiinfektiva GmbH, Dobecure SL, Heidelberg Immunotherapeutics Gmbh, Rational Vaccines Inc, and Vironova Medical AB |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Herpes Labialis (Oral Herpes) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Herpes Labialis (Oral Herpes) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Herpes Labialis (Oral Herpes) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Herpes Labialis (Oral Herpes) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Herpes Labialis (Oral Herpes) (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Herpes Labialis (Oral Herpes) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Astellas Pharma Inc
Brandenburg Antiinfektiva GmbH
Dobecure SL
Heidelberg Immunotherapeutics Gmbh
Jupiter Wellness Inc
NanoViricides Inc
Rational Vaccines Inc
Shulov Innovative Science Ltd
Vironova Medical AB
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Herpes Labialis pipeline products market?
The key targets in the Herpes Labialis pipeline products market are Cannabinoid Receptor 2, Prostaglandin G/H Synthase 2, DNA, DNA Helicase, DNA Primase, Fibroblast Growth Factor, Lipopolysaccharide, and Matrix Metalloproteinase 9.
-
What are the key mechanisms of action in the Herpes Labialis pipeline products market?
The key mechanisms of action in the Herpes Labialis pipeline products market are Cannabinoid Receptor 2 Agonist, Prostaglandin G/H Synthase 2 Inhibitor, DNA Helicase Inhibitor, DNA Primase Inhibitor, DNA Synthesis Inhibitor, Fibroblast Growth Factor Inhibitor, Lipopolysaccharide Inhibitor, and Matrix Metalloproteinase 9 Inhibitor.
-
What are the key routes of administration in the Herpes Labialis pipeline products market?
The key routes of administration in the Herpes Labialis pipeline products market are topical, oral, intravenous, intravitreal, nasal, and vaginal.
-
What are the key molecule types in the Herpes Labialis pipeline products market?
The key molecule types in the Herpes Labialis pipeline products market are small molecule, synthetic peptide, live attenuated vaccine, and monoclonal antibody.
-
Which are the leading companies in the Herpes Labialis pipeline products market?
The leading companies in the Herpes Labialis pipeline products market are Jupiter Wellness Inc, NanoViricides Inc, Shulov Innovative Science Ltd, AiCuris Anti-infective Cures AG, Astellas Pharma Inc, Brandenburg Antiinfektiva GmbH, Dobecure SL, Heidelberg Immunotherapeutics Gmbh, Rational Vaccines Inc, and Vironova Medical AB.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.